News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current CVKD market cap is 6.88M. The company's latest EPS is USD -0.5220 and P/E is -0.82.
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -973k | -4.2M | -1.03M | -1.14M |
| Net Income | -1.03M | -5.17M | -1M | -1.04M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -2.7M | -7.63M |
| Net Income | -6.71M | -8.36M |
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Total Assets | 545k | 4.48M | 3.56M | 9.31M |
| Total Liabilities | 1.73M | 417k | 383k | 566k |
| Total Equity | -1.18M | 4.07M | 3.18M | 8.75M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 778k | 8.52M |
| Total Liabilities | 6.33M | 827k |
| Total Equity | -5.55M | 7.69M |
| Market Cap | 6.88M |
| Price to Earnings Ratio | -0.82 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.82 |
| Price to Book Ratio | 0.89 |
| Dividend Yield | - |
| Shares Outstanding | 16.01M |
| Average Volume (1 week) | 162.3k |
| Average Volume (1 Month) | 501.87k |
| 52 Week Change | -73.63% |
| 52 Week High | 3.14 |
| 52 Week Low | 0.36 |
| Spread (Intraday) | 0.04 (8.79%) |
| Company Name | Cadrenal Therapeutics Inc |
| Address |
651 n broad st suite 201 middletown, delaware 19709 |
| Website | https://www.cadrenal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
